# Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add‐on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/durability-of-glycaemic-efficacy-over-2-years-with-dapagliflozin-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael A. Nauck,Stefano Del Prato,S. Durán‐García,Katja Rohwedder,Anna Maria Langkilde,Jennifer Sugg,Shamik Parikh |
| Citations | 114 |
| DOI | 10.1111/dom.12327 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2065946881 |
| PMID | 24919526 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Katja Rohwedder](https://scholariq.org/researchers/katja-rohwedder/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.